Letter: Optimum phenytoin-dosage regimens (Q39367654)

11 September 2017

title

Letter: Optimum phenytoin-dosage regimens (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55621

9 April 2022

T. M. Ludden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55621

9 April 2022

D. W. Hawkins

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55621

9 April 2022

J. P. Allen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55621

9 April 2022

S. F. Hoffman

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55621

9 April 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

11 September 2017

7 February 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55621

full work available at URL

9 April 2022

https://api.elsevier.com/content/article/PII:S0140673676914410?httpAccept=text/xml

1 reference

10.1016/S0140-6736(76)91441-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91441-0

https://api.elsevier.com/content/article/PII:S0140673676914410?httpAccept=text/plain

9 April 2022

1 reference

10.1016/S0140-6736(76)91441-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91441-0

9 April 2022

1 reference

11 September 2017

1 reference

11 September 2017

issue

7954

1 reference

11 September 2017

page(s)

307-308

1 reference

Serum-phenytoin levels in management of epilepsy

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Letter: Serum-phenytoin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Phenytoin dose adjustment in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Diphenylhydantoin elimination kinetics in overdosed children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Letter: Phenytoin dosage nomogram

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Malignant Lymphoma Associated With Hydantoin Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Malignant lymphoma after diphenylhydantoin (dilantin) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Letter: Subnormal lymphocyte-counts in adult coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

Loss of suppressor function as a cause of lymphoid malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991441-0

7 January 2021

10.1016/S0140-6736(76)91441-0

Identifiers

DOI

1 reference

11 September 2017

1 reference